Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03606083 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry in Patients With Aorto-iliac or Iliac Aneurysms

Study acronym: PLIANTII
StatusActive, Not Recruiting
PhaseNot specified
SponsorJOTEC GmbH
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 30, 2024 to Sep 30, 2028
    • Publications: 2 to 3
    v6
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 400 to confirmed 298
    • Primary completion date: Sep 30, 2024 to Dec 30, 2024
    • Site details revised
    v5
  3. 3 versions Re-verified since Aug 14, 2019, no change to tracked fieldsv2-v4
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
JOTEC GmbH
14 trials monitored
See 1 trial at risk
The PLIANT II registry is undertaken to examine the real-world outcome after treatment of consecutive patients with uni- or bilateral aorto-iliac or iliac aneurysms using the E-liac Stent Graft System.
Trial Details
NCT Number NCT03606083
Lead Sponsor JOTEC GmbH
Conditions
(from sponsor)		 Vascular Aneurysm
Related terms Aneurysm
Enrollment 298 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov